Clinical Trials Browser

Withdrawn × OTHER × glofitamab × Clear all

NCT06670105 2025-09-17

A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell Lymphoma

Phase 2 Withdrawn

Lymphoma, B-Cell